BBP

Fund Description
Virtus LifeSci Biotech Products ETF (the "Products Fund") is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the performance of the LifeSci Biotechnology Products Index. Products stage companies are typically more established companies with much clinical trial failure risk behind them.
Fund Profile
Fund Name Virtus LifeSci Biotech Products ETF
Fund Exchange Ticker BBP
Fund Sponsor Bioshares
Fund ISIN US26923G2021
Net Expense Ratio 0.79 %
Fund Inception Date 17 December 2014
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name LifeSci Biotechnology Products Index
Index Provider LifeSci Index Partners
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 14 June 2019
Asset Under Management 34.33 Million (USD)
1 Month Total Return -4.33 %
Year To Date Return 9.26 %
1 Year Total Return -13.37 %
3 Year Annualized Total Return 12.26 %
NAV 38.1455
Share Outstanding 900,004
Top 10 Holdings (14 June 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
UNIQURE NV QURE EQUI 0.0256
VOYAGER THERAPEUTICS INC VYGR EQUI 0.0238
MIRATI THERAPEUTICS INC MRTX EQUI 0.0235
EIDOS THERAPEUTICS INC EIDX EQUI 0.0211
EPIZYME INC EPZM EQUI 0.0207
IOVANCE BIOTHERAPEUTICS INC IOVA EQUI 0.0199
ASCENDIS PHARMA A/S - ADR ASND EQUI 0.0195
ARQULE INC ARQL EQUI 0.0189
ZIOPHARM ONCOLOGY INC ZIOP EQUI 0.0182
ARROWHEAD PHARMACEUTICALS IN ARWR EQUI 0.0179